Carthamus tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes
Figure 5
Antitumor activity of the CT extract-treated DC vaccine in JC tumor-bearing mice. DC vaccine or CT-treated DC vaccine (DC-CT) was administered via intraperitoneal injection on day 13 when mean estimated tumor weight was >63 mg (0.5 × 0.5 cm in diameter). A group of tumor-bearing animals without treatment was the tumor control. Animals were sacrificed on day 32, and the tumors were excised and weighed. Data are expressed as mean ± SE
( in each group).
